|
Market Closed -
Nasdaq
16:00:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 6.260 USD | +1.29% |
|
-1.57% | +50.48% |
| 08-24 | Precision BioSciences, Inc. Commences Dosing In Phase 1/2 Function-Dmd Study | CI |
| 08-24 | Precision BioSciences Doses First Patient in Trial of Potential Duchenne Muscular Dystrophy Treatment | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DTIL | Delayed | |
CBOE
| DTIL | Real-time | |
Boerse Muenchen
| PBS0 | Real-time | |
Tradegate
| PBS0 | Real-time | |
Deutsche Boerse AG
| PBS0 | Delayed | |
Börse Stuttgart
| PBS0 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 7.19 | 9.28 | 8.85 |
| Spread/Res. | -12.93% | -32.54% | -29.27% |
| Spread/Supp. | +4.51% | +4.51% | +7.56% |
| Support | 5.99 | 5.99 | 5.82 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DTIL Stock
- Charts Precision BioSciences, Inc.
Select your edition
All financial news and data tailored to specific country editions

















